Skip to content

This is a website for UK healthcare professionals only.

This is a promotional website developed and funded by AstraZeneca.

The prescribing information can be found at the bottom of the page

bars

Tagrisso Case Studies

View cases by PROFILE (i.e. early stage, first line, second line) or by FORMAT
(i.e. podcasts, videos, interactive module) by selecting from the dropdown

chevron down


Tagrisso Case Study: First-Line EGFRm+ NSCLC – 45M

Dr Shobhit Baijal, Consultant Medical Oncologist, University Hospitals Birmingham

Tagrisso Case Study: First-line EGFRm+ NSCLC – 81F

Dr Ashley Cox, Consultant Clinical Oncologist Royal United Hospital Bath

Tagrisso Case Study: Second line EGFRm+ NSCLC – 63F

Dr David Woolf, Consultant Clinical Oncologist, Christie NHS Foundation Trust

Tagrisso Case Study: First line EGFRm+ NSCLC – 84F

Dr Tom Newsom-Davis, Consultant Medical Oncologist, Chelsea and Westminster NHS Foundation Trust

Tagrisso Case Study: First line EGFRm+ NSCLC – 71F

Dr Tom Newsom-Davis, Consultant Medical Oncologist, Chelsea and Westminster NHS Foundation Trust

Tagrisso Case Study: First line EGFRm+ NSCLC – 76F

Dr David Woolf, Consultant Clinical Oncologist, Christie NHS Foundation Trust

GB-57396
Date of Preparation: January 2025